🏠 Home Health + South Asia Health Tech 100

Happy Monday 👋

Home health is a powerful means to provide care and treatment, especially with an increasingly aging population and a higher prevalence of chronic diseases. In the health tech landscape, the spotlight is on South Asia with its vibrant health startup space. Don't forget to check out the 2024 Global Health Tech Outlook, and sign up for our Daily Newsletters Chart of the Day and Impact Capital Markets. For unlimited access to over one million charts, request a demo.

This Week's Topics

• 🏠 Home Health Market Map. 200+ companies across the home health landscape
• 📊 Charts Spotlight. US nursing care staff on the decline
• 📈 Health Diagnostics and Testing Index. Up 3% over the past 12 months
• 🏆 South Asia Health Tech 100. South Asia's most promising startups working in digital health, biotech, drug discovery, and analytics
• 📖 Annual Health Tech Outlook. 190+ pages of trends, insights, and data
• 💰 Health Tech Deals of the Week. Funding, M&A and IPOs

🏠 Home Health Landscape

As the number of people with chronic conditions and the aging population expands, home health plays a vital role in ensuring independence while providing convenient care and treatment options. It also allows patients to access and receive care at their doorsteps. Organizations in this space provide direct home health through doctor visits, home nursing, or personal care aides. In addition, we identify other technologies or platforms that enable patients to live independently, connect healthcare providers and care seekers, and assist healthcare providers in monitoring their patients

Several critical partnerships took place in the home health landscape over the past few weeks. Compassus (a US home health and hospice company) formed a joint venture with an Ohio-based health system Bon Secours Mercy Health to form a home health and hospice venture. Moreover, Instacart (an e-commerce plaform) partnered with DispatchHealth (an urgent home health company) to allow the company's care provider to order groceries and other necessities for their patients through Instacart's platform.

HolonIQ is tracking hundreds of global health companies in this area and through Q1 we're launching an enhanced Market Maps feature to explore landscapes dynamically on dimensions important to you, by region, revenue, age, category, and more with subcategorization on any dimension in one click. Stay tuned for the launch!

🏠 Home Health - Market Map

📊 Charts Spotlight - US Nursing Care Holds the Highest Professional Gap in Health

Subscribe to HolonIQ's 'Chart of the Day,' a daily newsletter that helps explain the global impact economy - from climate tech to education and healthcare.

Nurses constitute a significant portion of the home health employment in the US, with over 271,000 nurses employed in home health. Despite these numbers, there is a tremendous shortage of home health nurses, and it will continue to grow over the coming years. The difference between newly qualified nurses and vacancies in 2031 vastly outstrips the difference among other health professionals. Moreover, 1M nurses are expected to retire in the next 5 to 10 years, highlighting the dire need to replenish staffing needs for nurses in the coming years.

📈 Capital Markets - Health Diagnostics and Testing Index

HolonIQ tracks thousands of listed health companies around the world and several acquisitions and investments each year. Soon, we will launch a range of stock indices to track the daily performance of over 10 different sectors across Health Technology.

Our new Impact Capital Markets newsletter tracks over 60 impact stock indices, including climate tech, emerging economies, and over 50 indices tracking healthcare innovation and education technology. Subscribe to Impact Capital Markets for data-driven insights on capital powering impact.

The Health Diagnostics and Testing Index recorded positive growth after a 15% decline in 4Q 2023 despite reduced COVID-19 diagnostics sales. Strong performances from core players drove the rebound. While some major stocks saw losses, new technologies like self-testing and point-of-care options offer future growth potential. Wider adoption beyond traditional settings presents further opportunities, while COVID's impact diminishes as the world adjusts to the new normal.

🏆 South Asia Health Tech 100

The South Asia Health Tech 100 is HolonIQ’s annual list of the most promising startups working in digital health, biotech, drug discovery, and analytics in the region.

The cohort has seen high activity over the past several weeks. Wellthy Therapeutics (an Indian Chronic disease platform) was acquired by TruDoc (a UAE-based telehealth company) on February 13. Qure.ai (an Indian MedTech company) partnered with Project Data Sphere (an open-access cancer research platform) to enhance tumor assessments through AI-based solutions.

📊 2024 Global Health Tech Outlook

2024 is a fresh start and the stage is set for the next wave of Health Technology. Just a few weeks ago, we launched the 2024 Global Health Tech Outlook, HolonIQ's annual analysis of the health landscape, presenting over 190 pages of detailed market data, investment & analysis, strategic shifts, and trends in healthcare services, pharmaceuticals, biotechnology, and medical hardware. Download the extract or purchase the full report. You may also be interested in our Global Economic Outlook, Global Climate Tech Outlook, or Global Education Outlook.

We have a jam-packed agenda for 2024 including a major new market sizing release and many more exciting new initiatives. Stay tuned or Connect with HolonIQ to learn more about how we support forward-thinking institutions, governments, and organizations globally as they navigate the challenges and opportunities ahead. Purchase the Outlook or Download the Extract.

💰 Health Tech Deals of the Week

HolonIQ actively monitors and tracks deals in the Health industry, spanning across all regions of the world. Subscribe to our Daily Capital Markets newsletter to peruse the top deals for each day.

Funding

🧬 enGene, a clinical-stage genetic medicine company, raised $200M in a venture round to develop their genetic therapeutic candidate.

🎗️ Freenome, a US-based genomics platform for cancer detection company, raised $257M Series E, focusing on testing its early cancer detection platform.

🦷 MB2 Dental, a US-based dental office management company, secured a $2.3B debt facility, focusing on the use for future acquisitions and growth.

M&A

🩹 AstraZeneca, a global, science-led biopharmaceutical business, has acquired Icosavax for $1.1B, focusing on its lead product targeting respiratory viruses.

💡 Beedie Capital, a multi-strategy direct investment platform, has acquired Think Research for $63M, a Canadian decision support company.

💳 Blue Cross Blue Shield Louisiana, a US-based insurance organization, has halted acquiring Elevance Health for $2.5B, due to regulatory concerns from state lawmakers.

IPO

🧬 Prime Medicine, a US-based gene editing company, seeks to raise a $140M public offering to advance its pipeline of one-shot therapies for severe genetic disorders

Closures

🦽 Bridgeway, a US community-based health and human service for disabled people, is to cease operations since it is not meeting the demand, and the closure is effective March 15.

👵 Petersen Healthcare, a US-based company that runs about 100 nursing homes, is to cease 19 of those facilities due to inadequate state and federal funding and staffing challenges.

📊 Astarte Medical, a US-based clinical intelligence company, is to cease operations since it found difficulties in meeting investor targets, including doubling its customer base and introducing another product

Thank you for reading. Have a great week ahead!
Have some feedback or want to sponsor this newsletter? Let us know at hello@holoniq.com